A new phase 1 trial will test aerosolized chemotherapy in patients with cancer; Uber and NimbleRx partner to deliver prescriptions; Missouri prisons see a rise in coronavirus disease 2019 (COVID-19) cases.
Surgical researchers at City of Hope will become the first in the nation to open a clinical trial of aerosolized chemotherapy. The potential method of delivering chemotherapy could become an effective alternative for patients with abdominal cancer who have limited treatment options. When tumors present in ovarian, uterine, gastric, and colorectal cancers spread to the peritoneum in the abdomen, they become difficult to treat using intravenous chemotherapy. The pressurized intraperitoneal aerosolized chemotherapy (PIPAC) will soon be implemented in a multisite 3-year phase 1 clinical trial.
NimbleRx, an online pharmacy delivery company, has partnered with Uber Health to offer contactless prescription delivery from pharmacies in Seattle, Washington, and Dallas, Texas, according to The Associated Press. The companies hope to expand services to other parts of the country soon. The service is fully integrated with Uber’s platform while NimbleRx works directly with independent and regional pharmacies. NimbleRx already offers next-day delivery to 70% of the US population and same day delivery to 30%. Uber Health is also a HIPAA-secure platform and currently consists of nonemergency medical transportation for patients.
Missouri prisons reported 333 new cases of coronavirus disease 2019 (COVID-19) so far this month, marking a more than 50% increase from last month, The Associated Press reports. In comparison, the prison system has reported 661 total cases since the beginning of the pandemic. A prison spokeswoman attributes the rise to increased testing. Since August 1, confirmed cases rose from 105 to 232 at the Eastern Reception, Diagnostic and Correctional Center in Bonne Terre and from 108 to 163 at the Missouri Eastern Correctional Center in Pacific.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More